Cargando…
A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy
Concomitant with nephrotic syndrome and multicentric castleman's disease (MCD) has only been described in a limited number of small studies and case reports. Among those, none confirmed the renal pathology prior to the onset of MCD, and none of the cases had a history of nephrotic syndrome. A 7...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977547/ https://www.ncbi.nlm.nih.gov/pubmed/36873956 http://dx.doi.org/10.1155/2023/4926000 |
_version_ | 1784899315979780096 |
---|---|
author | Nakajima, Shuhei Nagai, Kei Sakata, Akiko Usui, Joichi Yamagata, Kunihiro Ueda, Atsushi |
author_facet | Nakajima, Shuhei Nagai, Kei Sakata, Akiko Usui, Joichi Yamagata, Kunihiro Ueda, Atsushi |
author_sort | Nakajima, Shuhei |
collection | PubMed |
description | Concomitant with nephrotic syndrome and multicentric castleman's disease (MCD) has only been described in a limited number of small studies and case reports. Among those, none confirmed the renal pathology prior to the onset of MCD, and none of the cases had a history of nephrotic syndrome. A 76 year-old Japanese man visited a nephrologist because of incident nephrotic syndrome. He had previously experienced three episodes of nephrotic syndrome, the last one 13 years ago, and had been diagnosed with membranous nephropathy by renal biopsy. Apart from these previous episodes, he also suffered from systemic lymphadenopathy, anemia, elevated C-reactive protein, polyclonal hypergammopathy, and elevated interleukin (IL)-6. An inguinal lymph node biopsy revealed CD138-positive plasma cells in the interfollicular region. Based on these findings, MCD was diagnosed. Renal biopsy indicated primary membranous nephropathy with spike lesions and bubbling in the basement membranes and deposition of immunoglobulin (Ig) G, IgA, IgM, and phospholipase A2 receptor along the glomerular basement membrane. Corticosteroid monotherapy successfully reduced the edema, proteinuria, and IL-6, but hypoalbuminemia was not sufficiently improved due to castleman's disease and remission of the nephrotic syndrome was not achieved. Later, tocilizumab was administered for remission induction in another facility. To the best of our knowledge, this represents the first report of Castleman's disease with previously diagnosed membranous nephropathy. This case does not provide a causal mechanism for the pathophysiology, but it may be worth suggesting possible involvement of MCD as a trigger for recurrence of membranous nephropathy. |
format | Online Article Text |
id | pubmed-9977547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-99775472023-03-02 A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy Nakajima, Shuhei Nagai, Kei Sakata, Akiko Usui, Joichi Yamagata, Kunihiro Ueda, Atsushi Case Rep Nephrol Case Report Concomitant with nephrotic syndrome and multicentric castleman's disease (MCD) has only been described in a limited number of small studies and case reports. Among those, none confirmed the renal pathology prior to the onset of MCD, and none of the cases had a history of nephrotic syndrome. A 76 year-old Japanese man visited a nephrologist because of incident nephrotic syndrome. He had previously experienced three episodes of nephrotic syndrome, the last one 13 years ago, and had been diagnosed with membranous nephropathy by renal biopsy. Apart from these previous episodes, he also suffered from systemic lymphadenopathy, anemia, elevated C-reactive protein, polyclonal hypergammopathy, and elevated interleukin (IL)-6. An inguinal lymph node biopsy revealed CD138-positive plasma cells in the interfollicular region. Based on these findings, MCD was diagnosed. Renal biopsy indicated primary membranous nephropathy with spike lesions and bubbling in the basement membranes and deposition of immunoglobulin (Ig) G, IgA, IgM, and phospholipase A2 receptor along the glomerular basement membrane. Corticosteroid monotherapy successfully reduced the edema, proteinuria, and IL-6, but hypoalbuminemia was not sufficiently improved due to castleman's disease and remission of the nephrotic syndrome was not achieved. Later, tocilizumab was administered for remission induction in another facility. To the best of our knowledge, this represents the first report of Castleman's disease with previously diagnosed membranous nephropathy. This case does not provide a causal mechanism for the pathophysiology, but it may be worth suggesting possible involvement of MCD as a trigger for recurrence of membranous nephropathy. Hindawi 2023-02-22 /pmc/articles/PMC9977547/ /pubmed/36873956 http://dx.doi.org/10.1155/2023/4926000 Text en Copyright © 2023 Shuhei Nakajima et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Nakajima, Shuhei Nagai, Kei Sakata, Akiko Usui, Joichi Yamagata, Kunihiro Ueda, Atsushi A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy |
title | A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy |
title_full | A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy |
title_fullStr | A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy |
title_full_unstemmed | A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy |
title_short | A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy |
title_sort | case of castleman's disease during the long-term course of membranous nephropathy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977547/ https://www.ncbi.nlm.nih.gov/pubmed/36873956 http://dx.doi.org/10.1155/2023/4926000 |
work_keys_str_mv | AT nakajimashuhei acaseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT nagaikei acaseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT sakataakiko acaseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT usuijoichi acaseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT yamagatakunihiro acaseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT uedaatsushi acaseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT nakajimashuhei caseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT nagaikei caseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT sakataakiko caseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT usuijoichi caseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT yamagatakunihiro caseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy AT uedaatsushi caseofcastlemansdiseaseduringthelongtermcourseofmembranousnephropathy |